NeuroDigm's Model Reveals the Reversal of Chronic Pain

Published: Feb 04, 2008

FT. WORTH, Texas--(BUSINESS WIRE)--Mary Hannaman MD, president of NeuroDigm Co. in Fort Worth, Texas has confirmed that a recombinant human erythropoietin, epoetin alfa, can reverse neural changes that cause chronic pain behavior. Using their Biogenic Model of Chronic Pain™, epoetin alpha was applied once locally in micro doses to the affected nerves resulting in the reversal of pain behaviors permanently.

Back to news